Pitolisant

Pitolisant

SCHEMBL6052604

CC1CCCN(CCCOCCCc2ccccc2)C1.CC1CCN(CCCOCCCc2ccccc2)CC1.C[C@@H]1C[C@H](C)CN(CCCOCCCc2ccccc2)C1.C[C@H]1C[C@H](C)CN(CCCOCCCc2ccccc2)C1.Clc1ccc(CCCOCCCN2CCCCC2)cc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH3

The experimentally established mechanism targets of Pitolisant. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 known ✓ Q9Y5N1 16/20 0.61
SLC6A2 P23975 2/20 0.61
HRH1 P35367 2/20 0.61
CHRM2 P08172 1/20 0.61
ADRA2C P18825 1/20 0.61
SLC6A4 P31645 1/20 0.61
SLC6A3 Q01959 1/20 0.61
KCNH2 Q12809 1/20 0.61
CACNA1C Q13936 1/20 0.61
SCN5A Q14524 1/20 0.61
SIGMAR1 Q99720 2/20 0.60
CHRM4 P08173 1/20 0.60
HTR2C P28335 1/20 0.60
HTR7 P34969 1/20 0.60
TMEM97 Q5BJF2 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6052840 0.95 HRH3 (0.64) HRH3SLC6A2HRH1CHRM2ADRA2C
SCHEMBL6052607 0.86 SIGMAR1 (0.65) HRH3SIGMAR1
SCHEMBL491602 0.84 HRH3 (0.68) HRH3
SCHEMBL491873 0.83 HRH3 (0.63) HRH3SLC6A2HRH1CHRM2ADRA2C
SCHEMBL491900 0.83 HRH3 (0.63) HRH3SLC6A2HRH1CHRM2ADRA2C
SCHEMBL491585 0.83 HRH3 (0.63) HRH3SLC6A2HRH1CHRM2ADRA2C
SCHEMBL491791 0.82 HRH3 (0.72) HRH3SLC6A2HRH1CHRM2ADRA2C
SCHEMBL12741679 0.81 HRH3 (0.61) HRH3SIGMAR1
SCHEMBL5484748 0.81 HRH3 (0.61) HRH3SIGMAR1
SCHEMBL491586 0.81 HRH3 (0.61) HRH3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1641461-A1 COMBINATION PRODUCT COMPRISING AN ANTAGONIST OR INVERSE AGONIST OF HISTAMINE RECEPTOR H<SB>3</SB>AND AN ANTIPSYCHOTIC OR ANTIDEPRESSANT AGENT, AND USE THEREOF FOR THE PREPARATION OF A MEDICAMENT THAT PREVENTS THE ADVERSE EFFECTS OF PSYCHOTROPIC DRUGS BIOPROJET (FR) 2006-04-05 EP disclosed
WO-2005000315-A1 COMBINATION PRODUCT COMPRISING AN ANTAGONIST OR INVERSE AGONIST OF HISTAMINE RECEPTOR H3 AND AN ANTIPSYCHOTIC OR ANTIDEPRESSANT AGENT, AND USE THEREOF FOR THE PREPARATION OF A MEDICAMENT THAT PREVENTS THE ADVERSE EFFECTS OF PSYCHOTROPIC DRUGS BIOPROJET (FR) 2005-01-06 WO disclosed